Qingdao Haici Hospital
11
3
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions
Role: collaborator
Evaluation of the Clinical Outcomes of the Embolic Protection System in Preventing Distal Embolism During Femoropopliteal Debulking Procedures
Role: collaborator
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Role: collaborator
Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD
Role: collaborator
A Real-world Study to Evaluate the Effectiveness of Intravascular Lithotripsy in Moderate to Severe Calcification Lesion of Lower Extremity Femoropopliteal Artery
Role: collaborator
Prospective Multicenter Registry on the Endovascular Treatment in Critical Limb Threatening Ischemia With Below the Knee Lesions With Wound, Ischemia, and Foot Infection (WIFI) Assessment
Role: collaborator
The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions
Role: collaborator
Results of Endovascular Treatment for Infrapopliteal Arterial Occlusive Disease.
Role: collaborator
Predictive Value of the Global Limb Anatomic Staging System (GLASS) in Patients With Critical Limb-threatening Ischemia
Role: collaborator
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions
Role: collaborator
Evaluation of Antithrombotic STrategies in STEMI Patients in China
Role: collaborator
All 11 trials loaded